The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJH.L Regulatory News (MJH)

  • There is currently no data for MJH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Agreement

24 Feb 2023 07:33

RNS Number : 9710Q
MJ Hudson Group PLC
24 February 2023
 

MJ Hudson Group plc

(the "Company", "Group" or "MJ Hudson")

 

Loan Agreement

 

 

MJ Hudson Group plc (AIM:MJH), the specialist service provider to the asset management industry, announces that, on 23 February 2023, the Company reached an agreement with its existing Senior Lender to provide a short term overdraft facility in total of £1.5m in order to provide the Company with working capital while it undertakes the current sales process. The short term facility will bear 5% interest plus the Bank of England's base rate per annum, plus additional fees as agreed with the Senior Lender.

 

As part of the arrangement the Company's former CEO and founder, Matthew Hudson, has agreed to provide the Company with a shareholder loan of £100,000. The loan is subordinate to the Senior Lender and carries the same interest rate. The loan and interest can only be repaid when Santander has agreed to its repayment in writing.

 

As Mr Hudson is a substantial shareholder, his loan represents a related party transaction. The directors consider, having consulted with the Company's Nominated Adviser, Cenkos Securities, that the terms of the loan are fair and reasonable insofar as its shareholders are concerned.

 

 

 

For further information, please contact:

 

MJ Hudson Group plc

Geoff Miller, Executive Chairman

 

Cenkos Securities plc (Nomad and Broker)

Giles Balleny

Stephen Keys

Callum Davidson

+44 20 7397 8900

 

Buchanan (PR Adviser)

Chris Lane

Jack Devoy

George Cleary

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFIFVDFLISFIV
Date   Source Headline
25th May 20237:00 amRNSCancellation - MJ Hudson Group plc
17th May 202311:04 amRNSCompletion of Disposal & Cancellation
4th May 20237:00 amRNSResults of Extraordinary General Meeting
11th Apr 20237:00 amRNSCompany Update
31st Mar 202310:31 amRNSDelay to Publication of Interim Results
10th Mar 20239:00 amRNSSale of UK Fund Management Business
7th Mar 202310:00 amRNSLoan Agreement
24th Feb 20237:33 amRNSLoan Agreement
23rd Feb 202311:07 amRNSDisclosure Regarding Related Party Transactions
15th Feb 20231:18 pmRNSResignation of CEO
13th Feb 20237:00 amRNSResignation of Auditor
16th Jan 20237:00 amRNSCompany and Trading Update
19th Dec 20227:00 amRNSBoard Changes
12th Dec 20227:45 amRNSCompany update and suspension of trading
12th Dec 20227:45 amRNSSuspension - MJ Hudson Group plc
10th Nov 202211:23 amRNSNotification of Major Holdings
10th Nov 20227:00 amRNSSIP and PDMR Dealings
4th Nov 20227:29 amRNSESG Business Expansion
1st Nov 20227:00 amRNSDirectorate Change
1st Nov 20227:00 amRNSChange in role of Non-Executive Chairman
17th Oct 20224:40 pmRNSSecond Price Monitoring Extn
17th Oct 20224:36 pmRNSPrice Monitoring Extension
17th Oct 20222:06 pmRNSSecon Price Monitoring Extn
17th Oct 20222:06 pmRNSSecond Price Monitoring Extn
17th Oct 20222:01 pmRNSPrice Monitoring Extension
17th Oct 20222:01 pmRNSPrice Monitoring Extension
17th Oct 202211:05 amRNSSecond Price Monitoring Extn
17th Oct 202211:00 amRNSPrice Monitoring Extension
17th Oct 202211:00 amRNSPrice Monitoring Extension
17th Oct 202210:06 amRNSSecon Price Monitoring Extn
17th Oct 20229:05 amRNSSecond Price Monitoring Extn
17th Oct 20229:00 amRNSPrice Monitoring Extension
17th Oct 20229:00 amRNSPrice Monitoring Extension
17th Oct 20227:00 amRNSChanges to guiance following auit ajustments
17th Oct 20227:00 amRNSChanges to guidance following audit adjustments
11th Oct 20227:00 amRNSSIP and PDMR Dealings
9th Sep 20223:31 pmRNSSIP and PDMR Dealings
1st Sep 20224:00 pmRNSNotification of Major Holdings
1st Sep 20221:10 pmRNSPDMR Dealings
31st Aug 20223:21 pmRNSResults of General Meeting and Issue of Equity
19th Aug 20224:20 pmRNSDirector’s Share Transfer
17th Aug 20227:00 amRNSInvestor Presentation
11th Aug 20227:00 amRNSResults of Placing and Retail Offer
10th Aug 20224:54 pmRNSRetail Offer
10th Aug 20224:41 pmRNSProposed Fundraise
9th Aug 20224:36 pmRNSSIP and PDMR Dealings
12th Jul 20227:00 amRNSSIP and PDMR Dealings
12th Jul 20227:00 amRNSTrading Update – Ahead of Expectations
14th Jun 20227:00 amRNSStrategic Partnership With Cork Gully
10th Jun 20226:01 pmRNSSIP and PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.